2-(3,5-dimethylpyrazol-1-yl)-5-fluoro-6-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]-N-pyrimidin-2-ylpyrimidin-4-amine
C19H23FN8O — CID 74223584
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(3,5-dimethylpyrazol-1-yl)-5-fluoro-6-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]-N-pyrimidin-2-ylpyrimidin-4-amine
2-(3,5-dimethylpyrazol-1-yl)-5-fluoro-6-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]-N-pyrimidin-2-ylpyrimidin-4-amine (PubChem CID 74223584) has the molecular formula C19H23FN8O and a molecular weight of 398.45 g/mol. Its IUPAC name is 2-(3,5-dimethylpyrazol-1-yl)-5-fluoro-6-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]-N-pyrimidin-2-ylpyrimidin-4-amine.
Molecular Properties
| Compound Name | 2-(3,5-dimethylpyrazol-1-yl)-5-fluoro-6-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]-N-pyrimidin-2-ylpyrimidin-4-amine |
|---|---|
| PubChem CID | 74223584 |
| Molecular Formula | C19H23FN8O |
| Molecular Weight | 398.45 g/mol |
| Exact Mass | 398.20 |
| IUPAC Name | 2-(3,5-dimethylpyrazol-1-yl)-5-fluoro-6-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]-N-pyrimidin-2-ylpyrimidin-4-amine |
| SMILES | COC[C@H]1CCCN1c1nc(-n2nc(C)cc2C)nc(Nc2ncccn2)c1F |
| InChI | InChI=1S/C19H23FN8O/c1-12-10-13(2)28(26-12)19-24-16(23-18-21-7-5-8-22-18)15(20)17(25-19)27-9-4-6-14(27)11-29-3/h5,7-8,10,14H,4,6,9,11H2,1-3H3,(H,21,22,23,24,25)/t14-/m1/s1 |
| InChIKey | CCFOHIBFCMNIPU-CQSZACIVSA-N |
| XLogP | 2.57 |
| TPSA | 93.88 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 398.45 |
| LogP ≤ 5 | 2.57 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 74223584 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.